1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 3:TABLE 3: Statistical analysis of differences in 〈D〉 and FA values in nine patients with high-grade glioma
Comparison Patients with a Statistically Significant Difference* 〈D〉 Value FA Edematous brain versus enhancing tumor margin 1–9 1, 4–9 Ipsilateral white matter versus enhancing tumor margin 1, 2, 4–9 1, 2, 4–9 Ipsilateral white matter versus edematous brain 1, 2, 4–9 1, 2, 4–9
Note.—In patient 3, T2-weighted EP images depicted abnormal signal intensity throughout the ipsilateral and contralateral centrum semiovale. In patient 9, T2-weighted EP images depicted abnormal signal intensity throughout ipsilateral centrum semiovale. Data in the contralateral centrum semiovale were used in this analysis.
* P < .05, post hoc Scheffé test.